费多尔·莫伊先科

Fedor Moiseenko

· Institute of Oncology NN Petrov
39h 指数
41,283总引用
219发文
55i10

简介

AI 合成简介
[Synthesized from academic records + research fields] Research interests: Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Gastric Cancer Management and Outcomes Recent publications: "Osimertinib after definitive CRT in unresectable stage III EGFR-mutated NSCLC: safety outcomes from the phase III LAURA study"; "Analysis of the efficacy and safety of regorafenib <i>versus</i> chemotherapy retreatment in 3<sup>rd</sup> line treatment of metastatic colorectal cancer"; "REACT: Real-world survival outcomes with atezolizumab, bevacizumab, and chemotherapy for treatment of advanced non-squamous NSCLC"

ℹ️ 本简介由 AI 根据教授关键词/学科资料合成, 非 ORCID 自填简介。如需准确信息, 请查阅 ORCID 官方档案或联系所属机构获取 CV。

研究方向

Lung Cancer Treatments and MutationsColorectal Cancer Treatments and StudiesCancer Genomics and DiagnosticsCancer Immunotherapy and BiomarkersGastric Cancer Management and Outcomes

数据来源: OpenAlex + ORCID + Wikidata · 数据质量: verified

登录后开启学术探索

收藏教授 / 论文 / 学科排名, 订阅研究方向更新。登录后开启这些能力。

已有账号?